QIAGEN and Abbott have entered into an agreement that significantly strengthens both companies’ testing menus for automated in vitro diagnostic applications in the United States and Canada.
Read MoreAs the United States prepares for the upcoming flu season, a group of researchers supported by the National Institutes of Health continues to model how H1N1 may spread.
Read MoreAt the first sign of a disease pandemic, public health officials should begin strongly communicating about the extent of the outbreak and the steps that can be taken by the public to avoid infection.
Read MoreCepheid announced that its Xpert MTB/RIF test was the subject of a study published in the latest edition of the New England Journal of Medicine (NEJM), “Rapid Molecular Detection of Tuberculosis and Rifampin Resistance.”
Read More
Inside this issue of CLP magazine, you’ll find our third annual respiratory virus supplement, which I hope you find useful as you prepare for the upcoming flu season. We are all breathing a bit easier now than we were at this time last y
Read More